💡 Did you know?
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
History
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Cyient DLM Limited is an integrated electronics manufacturing solutions provider that offers design led manufacturing (DLM) solutions to customers. The Company operates through manufacturing and providing the Electronic Manufacturing Services segment. It delivers design,…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A middling, fast-growing business, fully valued — but flagged on governance.
Cyient DLM is scored on the commodity / cyclical framework. It keeps a slim 5.7% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT 0.74×) — worth a closer look. Free cash flow is worth about 3.6% of its market value.
Over the last 3 years revenue compounded at 16%/yr and profit at 32%/yr. Book value itself has compounded 72%/yr — the hallmark of a genuine compounder. Return on equity is a weak 7.9%. In the latest quarter profit grew 109% versus the prior quarter.
At 84× earnings, the stock sits at the 73rd percentile of its own 3.3-year range — the middle of where it has historically traded. Today's price already implies ~27%/yr earnings growth sustained for a decade — a demanding bar. The forensic screen raises a red flag: Only ₹-0.11 of cash per ₹1 profit over 4 years — earnings not converting to cash.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 72.84 | 26.37 | worse |
| P/B | 5.73 | 6.26 | better |
| EV/EBITDA | 36.94 | 18.09 | worse |
| ROE | 7.86 | 6.99 | better |
| ROCE | 10.38 | 11.64 | worse |
| ROA | 4.8 | — | — |
| Quick Ratio | 1.17 | 1.61 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| HAL | 35.7 | 8.1 | 22.2% |
| BEL | 45.1 | 11.0 | 24.4% |
| Solar Industries (india) | 72.0 | 21.9 | 29.5% |
Revenue is on a 2-year growth streak. 16% CAGR over 3 years — steady double-digit compounder. Growth is decelerating — latest year grew slower than the year before.
Net profit has risen every year — the hallmark of a compounder. Profit is growing faster than revenue (32% vs 16%) — margin expansion is at work.
Operating margin has expanded from 5% to 7% — the business is keeping more of each rupee earned.
ROE at 7% — modest; the capital isn't working hard. Capital efficiency declining — ROE down 9pp.
EPS has grown every year — each share earns more than the last, consistently. Profit grew faster than EPS (32% vs 6%) — share dilution is eroding per-share value. 6% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
2 of 4 years had negative operating cash flow — profitability on paper may not translate to cash. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 11% sequentially — momentum is building. Run-rate stepping up — recent quarters average 16% above earlier ones.
Profit jumped 109% QoQ — check if this is operating leverage or a one-off item. Quarterly net margins are expanding (4% → 8%) — profitability per rupee of revenue is improving.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.3y median.
Promoter holding at 52.1% — majority control intact. MF stake down 2.5pp — domestic funds are booking profits or rebalancing out.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.